Noticias de ABT_US
Noticias del mercado
Últimas noticias sobre ABT_US — 804 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Abbott leads in absolute revenue, but Intuitive Surgical
Abbott lidera los ingresos absolutos, pero la tasa de crecimiento de Intuitive Surgical cuenta una historia diferente en los últimos ocho trimestres.
Abbott Laboratories pagará 384 millones de dólares para resolver las acusaciones de fraude a Medicaid. Carolina del Norte recibirá más de $216,000 del acuerdo.
At the close on September 18, 2026, Abbott Laboratories stock finished at USD 101.88 on the NYSE, do
This afternoon I fly from Seattle to Oslo. On Wednesday and Thursday, September 23 and 24, I give two talks at the Aquatiq Food Forum 2026 at the Clarion
Abbott Laboratories stock traded at USD 102.35 on September 19, 2026, after a nearly USD 385 million
Exact Sciences stock trades around USD 104 on Nasdaq as of September 18, 2026, above the consensus p
Abbott Laboratories stock traded at USD 102.35 on September 19, 2026, after June-quarter EPS of USD
A company-specific look at Abbott Laboratories, the current market theme surrounding ABT, its operating relevance and the evidence needed to assess what follows.
Detailed price information for Medtronic Inc (MDT-N) from The Globe and Mail including charting and trades.
A Pennsylvania woman is suing Abbott Laboratories and one of its subsidiaries in federal court, alleging she suffered permanent nerve damage as a result of a faulty spine implant and Abbott's representatives discouraging her from getting it removed.
A Pennsylvania woman is suing Abbott Laboratories and one of its subsidiaries in federal court, alleging she suffered permanent nerve damage as a result of a faulty spine implant and Abbott's representatives discouraging her from getting it removed.
The settlement resolves a lawsuit originally brought by three former Abbott employees under whistleblower protections.Naveen Athrappully ReporterAbbott Laboratories has agreed to pay more than $384 million to settle allegations that it manufactured infant formula under conditions that p
New York Attorney General Letitia James announced Thursday that Abbott Laboratories will pay more than $384 million to the federal government and a coalition of states over allegations involving the s...
Abbott Laboratories, la corporación detrás de Similac, no admitió ninguna irregularidad.
Nueva York/Nueva Jersey/CT | Abbott supuestamente engañó a los estados y al gobierno federal sobre la seguridad de su fórmula para bebés, lo que llevó a que Medicaid y WIC gastaran potencialmente en
Página 18 de 41